The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era

por Spagnuolo, Alessia, Muto, Matteo, Monaco, Fabio, Colantuoni, Giuseppe, Gridelli, Cesare
Publicado en Transl Lung Cancer Res (2019)

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Regi...

por Riccardi, Ferdinando, Colantuoni, Giuseppe, Diana, Anna, Mocerino, Carmela, Cartenì, Giacomo, Lauria, Rossella, Febbraro, Antonio, Nuzzo, Francesco, Addeo, Raffaele, Marano, Ombretta, Incoronato, Pasquale, De Placido, Sabino, Ciardiello, Fortunato, Orditura, Michele
Publicado en Mol Clin Oncol (2018)

Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting

por Prete, Salvatore Del, Montella, Liliana, Arpino, Grazia, Buono, Giuseppe, Buonerba, Carlo, Dolce, Pasquale, Fiorentino, Olga, Aliberti, Maria, Febbraro, Antonio, Savastano, Clementina, Colantuoni, Giuseppe, Riccardi, Ferdinando, Ruggiero, Angela, Placido, Sabino De, Orditura, Michele
Publicado en Oncotarget (2020)

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

por Puglisi, Fabio, Gerratana, Lorenzo, Lambertini, Matteo, Ceppi, Marcello, Boni, Luca, Montemurro, Filippo, Russo, Stefania, Bighin, Claudia, De Laurentiis, Michelino, Giuliano, Mario, Bisagni, Giancarlo, Durando, Antonio, Turletti, Anna, Garrone, Ornella, Ardizzoni, Andrea, Gamucci, Teresa, Colantuoni, Giuseppe, Gravina, Adriano, De Placido, Sabino, Cognetti, Francesco, Del Mastro, Lucia
Publicado en NPJ Breast Cancer (2021)